Ross M. Drayton - Publications

Identification and diagnostic performance of a small RNA within the PCA3 and BMCC1 gene locus that potentially targets mRNA.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: November 14, 2014

Identification of differentially expressed long noncoding RNAs in bladder cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: August 29, 2014

MicroRNA-99a and 100 mediated upregulation of FOXA1 in bladder cancer.

Journal: Oncotarget

Published: July 30, 2014

Reduced expression of miRNA-27a modulates cisplatin resistance in bladder cancer by targeting the cystine/glutamate exchanger SLC7A11.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 12, 2014

The role of microRNA in the response to cisplatin treatment.

Journal: Biochemical Society transactions

Published: July 24, 2012

An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer.

Journal: British journal of cancer

Published: May 31, 2012

Inhibition of poly(ADP-ribose) glycohydrolase (PARG) specifically kills BRCA2-deficient tumor cells.

Journal: Cell cycle (Georgetown, Tex.)

Published: February 16, 2012

Molecular mechanisms of cisplatin resistance in bladder cancer.

Journal: Expert review of anticancer therapy

Published: February 10, 2012